Koshibu Masakazu, Watanabe Natsuko, Suzuki Nami, Takahashi Yasuyoshi, Onda Hidetoshi, Kozaki Ai, Hiruma Shigenori, Ichikawa Masahiro, Hirose Rei, Imai Hideyuki, Sankoda Akiko, Fukushita Miho, Yoshihara Ai, Matsumoto Masako, Yoshimura Noh Jaeduk, Sugino Kiminori, Ito Koichi
Department of Internal Medicine, Ito Hospital, Japan.
Department of Internal Medicine, Division of Diabetes, Metabolism and Endocrinology, Showa University School of Medicine, Japan.
Intern Med. 2025 Apr 1;64(7):1061-1065. doi: 10.2169/internalmedicine.3872-24. Epub 2024 Sep 11.
A 37-year-old, never-smoker, pregnant woman diagnosed with Graves' disease who had stable thyroid eye disease (TED) before pregnancy presented with aggravated proptosis and eyelid swelling at 13 weeks of pregnancy. Despite the administration of local triamcinolone and 3 cycles of corticosteroid pulse therapy from 25 to 28 weeks, the patient's visual acuity decline necessitated postpartum orbital decompression surgery. Although thyroid stimulating hormone (TSH) receptor antibody levels decreased during the mid- to late term of pregnancy, the TED worsened. This finding suggests that factors other than anti-TSH receptor antibodies may have a significant effect on disease severity.
一名37岁、从不吸烟的孕妇,被诊断为格雷夫斯病,怀孕前患有稳定的甲状腺眼病(TED),在怀孕13周时出现眼球突出加重和眼睑肿胀。尽管在孕25至28周期间给予了局部曲安奈德和3个周期的皮质类固醇脉冲治疗,但患者视力下降,需要在产后进行眼眶减压手术。尽管在妊娠中期至晚期甲状腺刺激激素(TSH)受体抗体水平下降,但TED仍恶化。这一发现表明,除抗TSH受体抗体外的其他因素可能对疾病严重程度有显著影响。